Structure-based drug design is a rational drug discovery methodology that leverages the known three-dimensional structure of biological targets, typically proteins or nucleic acids, to guide the design and optimization of potential therapeutic agents. This approach employs computational and experimental techniques to analyze the target's binding site and interactions with potential ligands, enabling the systematic identification and development of molecules with desired binding affinity, specificity, and pharmacological properties, thereby accelerating the drug development process.